HighTower Advisors’s Cellectis CLLS Stock Holding History

HighTower Advisors’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-15,140	Closed	-$426K	–	2226
2018 Q3	$426K	Buy	+15,140	New	+$435K	﹤0.01%	1536
2017 Q1	–	Sell	-12,330	Closed	-$210K	–	2094
2016 Q4	$210K	Sell	12,330 -1,235	-9%	-$22.8K	﹤0.01%	1655
2016 Q3	$327K	Buy	13,565 +125	+0.9%	+$3.27K	﹤0.01%	1416
2016 Q2	$357K	Buy	13,440 +40	+0.3%	+$1.17K	﹤0.01%	1261
2016 Q1	$369K	Buy	+13,400	New	+$323K	﹤0.01%	1513

Other funds holding CLLS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors's CLLS Position: Q4 2018 in Review

HighTower Advisors sold out of Cellectis (CLLS) in Q4 2018, closing a stake of 15,140 shares — an estimated $426K sold.

HighTower Advisors first reported a position in CLLS in Q1 2016 and held it in 5 quarters. The position peaked at $426K in Q3 2018. 65 funds tracked by Wall St. Rank hold CLLS as of Q4 2018.

HighTower Advisors reported no remaining Cellectis position as of Q4 2018 after selling out during the quarter.
HighTower Advisors sold 15,140 Cellectis shares in Q4 2018, an estimated $426K.
HighTower Advisors first reported a position in Cellectis in Q1 2016 and held it in 5 quarters.
HighTower Advisors's Cellectis position peaked at $426K in Q3 2018.
65 funds tracked by Wall St. Rank held Cellectis as of Q4 2018.

Based on HighTower Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.